Navidea wins SBIR grant; Alcohol abuse and eating disorders share genetic link;

@FierceBiotech: Popular yesterday: Novartis wins a record breakthrough therapy designation for orphan drug. Article | Follow @FierceBiotech

@JohnCFierce: Just came across my story on first IPO of '13 - $STML, priced at $10, now $34.55. Hopeful signs, indeed. Article | Follow @JohnCFierce

@EmilyMFierce: This week's issue of FierceBiotechResearchReport | Follow @EmilyMFierce

> Navidea Biopharmaceuticals ($NAVB) says it won a Small Business Innovation Research (SBIR) grant from the National Institute On Aging in connection with the Phase III clinical program for its NAV4694 beta-amyloid imaging agent for Alzheimer's. Release

> A Taiwan-based biotech startup dubbed TaiGen Biotechnology is being listed on a local exchange. Yuen Goong Yu Group, a paper manufacturer, is launching the company. Story

Medical Device News

@FierceMedDev: Popular this week: Inventor launches crowdfunding hub for medical devices. Article | Follow @FierceMedDev

@DamianFierce: Finally, some good news for Navidea: Medicare expansion and a Siemens partnership. Report | Follow @DamianFierce

@MarkHFierce: In 2012, medical device employment at the top companies mostly grew, due to M&A and organic growth. ICYM the feature | Follow @MarkHFierce

> Boston Scientific wins FDA nods for electrophysiology tech. More

> Medtronic's Ishrak outlines health services expansion plans. Article

> Quest dumps $1B into repurchase plan as sales ail. Story

> Acutus Medical closes $28M round for arrhythmia mapping device. Item

Pharma News

@FiercePharma: Novartis picks Dublin site for new regional business center, on track for 100 new jobs there. More | Follow @FiercePharma

@EricPFierce: Alexion recalls some Soliris in EC "due to the presence of visible particles in a limited number of vials." More from FiercePharmaManufacturing | Follow @EricPFierce

@CarlyHFierce: Shire enlists help fighting unwanted takeover. Another co. seeking access to Ireland's tax regime? Popular yesterday from FiercePharma | Follow @CarlyHFierce

> China's pharma probe intensifies with British consultant's arrest. More

> India's Biocon promises Herceptin biosim launch by fiscal year-end. Article

> Allergan pushes FDA to defend Restasis from early generics. Report

Biomarkers News

> Blood samples may aid suicide risk prediction. Story

> Possible psychosis biomarker found in brain 'folding.' Story

> Potential Alzheimer's biomarker targeted in brain fluid. More

> Lung cancer gene variants could help boost survival odds. Article

> Biomarker gauges graft-versus-host disease risk for stem cell transplant patients. Item

Drug Delivery News

@MichaelGFierce: Time-release delivery of vision-loss drug demands fewer injections. More | Follow @MichaelGFierce

> Study: Insulin pumps improve glycemic control in children with diabetes. Story

> Bind launches second PhII trial for prostate cancer nanomed. More

> Alnylam wins two orphan designations for hemophilia RNAi drug. Report

> Platinum-based radiotherapy method zaps cancer with nanomeds. Article

And Finally… Researchers at Washington University School of Medicine say that alcohol abuse and eating disorders share some common genetic links. Story